Search:
   

Wednesday, May 3, 2017

Equity Trader Alert #2017 - 96
PharmAthene, Inc. (PIP) and Altimmune, Inc. to Merge and Begin Listing on Nasdaq on Friday, May 5, 2017

Category:

  • Industry Announcement

Markets Impacted:

Contact Information:

Resources:

PharmAthene, Inc. (NYSE MKT: PIP) and Altimmune, Inc. have completed a merger today, Thursday, May 4, 2017. Following the merger, PharmAthene, Inc. will have a corporate name and CUSIP change, undergo a 1 for 10 reverse stock split, and will begin trading on Nasdaq under the ticker symbol ALT. PharmAthene, Inc. will continue to be traded on NYSE MKT through the close of business on Thursday, May 4, 2017. The details are as follows:

Current Company Name: PharmAthene, Inc.
Issue: Common Stock
Current CUSIP: 71714G102
Current Symbol: PIP
New Company Name: Altimmune, Inc.
New CUSIP: 02155H101
New Symbol: ALT
Ratio of Reverse Split: 1 for 10
Marketplace Effective Date: May 5, 2017

For information regarding this announcement, contact Nasdaq Corporate Data Operations at +1 877 308 0523.

If you would like to register as a market maker in ALT, contact Nasdaq Trading Services at +1 212 231 5100.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Please follow Nasdaq on Facebook RSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.

View NASDAQTrader.com Mobile